A First in Human Study to Evaluate the Safety and Immunogenicity of RBM-001 in Healthy Adult Volunteers
Clinical trial NCT06878170 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06878170
- Sponsor
- Rock BioMedical, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-30
- Primary completion
- 2025-05-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.